| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.001 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.64 | 0.002 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |